Key result
Intraoperative defibrillation threshold testing during ICD implantation did not significantly influence long-term outcomes, with ventricular tachyarrhythmic events occurring in 6.8% of tested patients versus 5.1% of untested patients.
Why the study?
Does intraoperative defibrillation threshold (DFT) testing improve long-term outcomes in patients undergoing ICD or CRT-D implantation?
Cohort (n=150)
No
Does intraoperative defibrillation threshold (DFT) testing improve long-term outcomes in patients undergoing ICD or CRT-D implantation?
Routine defibrillation threshold testing during ICD implantation does not appear to improve long-term clinical outcomes, supporting the trend to defer such testing.
Answers are grounded in this paper and cite their sources.
Supports deferring routine DFT testing; hypothesis-generating and requires randomized confirmation before practice change.
Defibrillation threshold (DFT) testing is performed routinely in patients undergoing implantable cardioverter-defibrillator (ICD) implantation to verify the ability of the ICD to terminate ventricular fibrillation (VF). However, neither the efficacy nor the safety of DFT testing has been proven; thus, the necessity of such testing is controversial. We conducted a retrospective study of the efficacy of DFT testing, particularly with respect to long-term outcomes of ICD implantation.The study included 150 patients (125 men, 25 women, aged 59.0 ± 17.6 years) who underwent ICD or cardiac resynchronization therapy defibrillator implantation, with (n = 73) or without (n = 77) intraoperative DFT testing, between June 1996 and September 2007. VF was induced by delivery of a T-wave shock, and a 20-25-J shock was then delivered. If the 20-25-J shock failed to terminate VF, 30 J was delivered. We assessed whether undersensed VF events occurred during DFT testing and/or during patient follow-up and checked for any association between undersensing and delayed shock delivery. During DFT testing, fine VF was sensed, and shocks were delivered in a timely manner. Nevertheless, 2 patients in the DFT testing group died from VF within 3 years after device implantation.DFT testing, in comparison to non-DFT testing, appeared to have no influence on the long-term outcomes of our patients, suggesting that DFT testing at the time of ICD implantation is limited.
No takes yet. Share an insight, caveat, or question.
Ashino et al. (2015) conducted a cohort in Patients undergoing ICD or CRT-D implantation (n=150). Intraoperative defibrillation threshold (DFT) testing vs. No DFT testing was evaluated on Ventricular tachyarrhythmic events and appropriate shocks. Intraoperative defibrillation threshold testing during ICD implantation did not significantly influence long-term outcomes, with ventricular tachyarrhythmic events occurring in 6.8% of tested patients versus 5.1% of untested patients.
Synapse has enriched 10 related papers. Consider them for comparative context: